Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q2 2023 Earnings

3AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.68

-0.63

-0.59

-0.54

Details

Expected EPS

-0.63

Actual EPS

-0.54

Surprise EPS

0.09

Surprise Percent

+14.29%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.54 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.